Mechanism of action of glucocorticosteroid hormones: possible implications for therapy of neuroimmunological disorders

被引:91
作者
Gold, R
Buttgereit, F
Toyka, KV
机构
[1] Univ Wurzburg, Neurol Klin, Dept Neurol, Clin Res Grp Multiple Sclerosis & Neuroimmunol, D-97080 Wurzburg, Germany
[2] Humboldt Univ, Charite Univ Hosp, Dept Med Rheumatol, Berlin, Germany
关键词
multiple sclerosis; polyneuritis; myositis; autoimmunity;
D O I
10.1016/S0165-5728(01)00330-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Glucocorticosteroids are the most potent immunosuppressive and antiinflammatory drugs. Over the six decades that have passed since their discovery, a variety of genomic effector mechanisms of steroid hormones has been described which are mediated by the cytosolic steroid receptor. Recent evidence supports a direct effect of glucocorticosteroids on cellular membranes that occurs at higher hormone concentrations, termed nongenomic effects. These imply a qualitatively distinct mode of steroid action leading to cellular apoptosis. In this review, we discuss in vitro and in vivo data on nongenomic effects of glucocorticosteroids and their possible implications for the therapy of human neuroimmunological diseases. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 57 条
[1]   Impairment of TNF-receptor-1 signaling but not Fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice [J].
Bachmann, R ;
Eugster, HP ;
Frei, K ;
Fontana, A ;
Lassmann, H .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (05) :1417-1422
[2]   Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis [J].
Barnes, D ;
Hughes, RAC ;
Morris, RW ;
WadeJones, O ;
Brown, P ;
Britton, T ;
Francis, DA ;
Perkin, GD ;
Rudge, P ;
Swash, M ;
Katifi, H ;
Farmer, S ;
Frankel, J .
LANCET, 1997, 349 (9056) :902-906
[3]   A RANDOMIZED, CONTROLLED TRIAL OF CORTICOSTEROIDS IN THE TREATMENT OF ACUTE OPTIC NEURITIS [J].
BECK, RW ;
CLEARY, PA ;
ANDERSON, MM ;
KELTNER, JL ;
SHULTS, WT ;
KAUFMAN, DI ;
BUCKLEY, EG ;
CORBETT, JJ ;
KUPERSMITH, MJ ;
MILLER, NR ;
SAVINO, PJ ;
GUY, JR ;
TROBE, JD ;
MCCRARY, JA ;
SMITH, CH ;
CHROUSOS, GA ;
THOMPSON, HS ;
KATZ, BJ ;
BRODSKY, MC ;
GOODWIN, JA ;
ATWELL, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (09) :581-588
[4]   Cytotoxic mechanisms in inflammatory myopathies - Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells [J].
Behrens, L ;
Bender, A ;
Johnson, MA ;
Hohlfeld, R .
BRAIN, 1997, 120 :929-938
[5]   A RANDOMIZED, CONTROLLED TRIAL OF METHYLPREDNISOLONE OR NALOXONE IN THE TREATMENT OF ACUTE SPINAL-CORD INJURY - RESULTS OF THE 2ND NATIONAL ACUTE SPINAL-CORD INJURY STUDY [J].
BRACKEN, MB ;
SHEPARD, MJ ;
COLLINS, WF ;
HOLFORD, TR ;
YOUNG, W ;
BASKIN, DS ;
EISENBERG, HM ;
FLAMM, E ;
LEOSUMMERS, L ;
MAROON, J ;
MARSHALL, LF ;
PEROT, PL ;
PIEPMEIER, J ;
SONNTAG, VKH ;
WAGNER, FC ;
WILBERGER, JE ;
WINN, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (20) :1405-1411
[6]   Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials [J].
Brusaferri, F ;
Candelise, L .
JOURNAL OF NEUROLOGY, 2000, 247 (06) :435-442
[7]   DETERMINATION OF THE LENGTH OF THE HISTOLOGICAL STAGES OF APOPTOSIS IN NORMAL LIVER AND IN ALTERED HEPATIC FOCI OF RATS [J].
BURSCH, W ;
PAFFE, S ;
PUTZ, B ;
BARTHEL, G ;
SCHULTEHERMANN, R .
CARCINOGENESIS, 1990, 11 (05) :847-853
[8]   EFFECTS OF METHYLPREDNISOLONE ON THE ENERGY-METABOLISM OF QUIESCENT AND CONA-STIMULATED THYMOCYTES OF THE RAT [J].
BUTTGEREIT, F ;
BRAND, MD ;
MULLER, M .
BIOSCIENCE REPORTS, 1993, 13 (01) :41-52
[9]  
Buttgereit F, 2000, IMMUNOL TODAY, V21, P192
[10]   Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: A novel glucocorticoid hierarchy [J].
Buttgereit, F ;
Brand, MD ;
Burmester, GR .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (02) :363-368